A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
about
Specific in vivo knockdown of protein function by intrabodiesDual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival.Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
P2860
A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A bispecific transmembrane ant ...... ivation and tumor cell growth.
@en
A bispecific transmembrane ant ...... ivation and tumor cell growth.
@nl
type
label
A bispecific transmembrane ant ...... ivation and tumor cell growth.
@en
A bispecific transmembrane ant ...... ivation and tumor cell growth.
@nl
prefLabel
A bispecific transmembrane ant ...... ivation and tumor cell growth.
@en
A bispecific transmembrane ant ...... ivation and tumor cell growth.
@nl
P2093
P2860
P356
P1476
A bispecific transmembrane ant ...... ivation and tumor cell growth.
@en
P2093
Andrea Kinner
Cord Hartmann
Joachim Koch
Manuel Grez
Nina Müller
Sabrina Genssler
Winfried S Wels
P2860
P304
P356
10.1002/IJC.28585
P577
2013-11-18T00:00:00Z